Testing a breast-cancer prognostic tool with U.S. clinicians
Part of Cancer, Skin clinical trials.
This study checks how acceptable, appropriate, and easy to use a metastatic breast-cancer “prognostic calculator” is for clinicians. It may help clinicians use the tool in real practice to support care decisions for people with metastatic breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must agree to participate (provide verbal consent).
- You must be able and willing to follow the study steps as the study team asks.
- You must be a clinician such as a doctor, nurse practitioner, physician assistant, or nurse navigator.
- You need at least 6 months of experience caring for people with metastatic breast cancer in the United States.
- You must speak and be able to work in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new computer-based education module created by artificial intelligence to help breast cancer patients understand their diagnosis and treatment options. The goal is to see if this tool helps patients feel more informed and prepared for their care.
This study tests a palliative care program designed to improve quality of life for people with metastatic breast cancer. It may help you better manage symptoms and coordinate care with your oncology team.
This study tests whether a computer “avatar” made from your health information can help choose the best systemic therapy (medications that treat cancer throughout the body) for metastatic breast cancer. You may be asked to provide a tissue sample (biopsy) so the team can build and guide the treatment plan.
This study tests a digital tool called MyCareGorithm that helps patients understand their cancer treatment plans. It is for people with head and neck or prostate cancer, their caregivers, and their doctors.
This study is developing an educational tool to help women with endometrial cancer understand their diagnosis and treatment. It involves giving feedback on the tool and testing it during treatment.
This study is developing a questionnaire to better understand the experiences of women with metastatic breast cancer. It involves completing questionnaires and possibly interviews to help improve care and support for others with this condition.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.